The efficacy of terazosin for treating benign prostatic hyperplasia: a multicentre clinical trial

BJU Int. 2002 May;89(7):771-2. doi: 10.1046/j.1464-410x.2002.02715.x.
No abstract available

Publication types

  • Clinical Trial
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic alpha-Antagonists / administration & dosage*
  • Adrenergic alpha-Antagonists / adverse effects
  • Dose-Response Relationship, Drug
  • Humans
  • Male
  • Middle Aged
  • Prazosin / administration & dosage*
  • Prazosin / adverse effects
  • Prazosin / analogs & derivatives*
  • Prostatic Hyperplasia / drug therapy*
  • Treatment Outcome
  • Urinary Retention / drug therapy
  • Urinary Retention / etiology

Substances

  • Adrenergic alpha-Antagonists
  • Terazosin
  • Prazosin